|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: BORCS8 |
Gene summary for BORCS8 |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | BORCS8 | Gene ID | 729991 |
| Gene name | BLOC-1 related complex subunit 8 | |
| Gene Alias | MEF2BNB | |
| Cytomap | 19p13.11 | |
| Gene Type | protein-coding | GO ID | GO:0007275 | UniProtAcc | Q96FH0 |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 729991 | BORCS8 | LZE4T | Human | Esophagus | ESCC | 1.51e-03 | 1.20e-01 | 0.0811 |
| 729991 | BORCS8 | LZE7T | Human | Esophagus | ESCC | 6.97e-09 | 5.17e-01 | 0.0667 |
| 729991 | BORCS8 | LZE8T | Human | Esophagus | ESCC | 3.74e-03 | 1.00e-01 | 0.067 |
| 729991 | BORCS8 | LZE20T | Human | Esophagus | ESCC | 1.20e-09 | 2.39e-01 | 0.0662 |
| 729991 | BORCS8 | LZE22D1 | Human | Esophagus | HGIN | 6.12e-03 | 2.41e-01 | 0.0595 |
| 729991 | BORCS8 | LZE22T | Human | Esophagus | ESCC | 3.02e-05 | 3.03e-01 | 0.068 |
| 729991 | BORCS8 | LZE24T | Human | Esophagus | ESCC | 5.01e-21 | 4.80e-01 | 0.0596 |
| 729991 | BORCS8 | LZE6T | Human | Esophagus | ESCC | 3.49e-06 | 3.08e-01 | 0.0845 |
| 729991 | BORCS8 | P2T-E | Human | Esophagus | ESCC | 1.39e-13 | 1.27e-01 | 0.1177 |
| 729991 | BORCS8 | P4T-E | Human | Esophagus | ESCC | 1.87e-13 | 2.77e-01 | 0.1323 |
| 729991 | BORCS8 | P5T-E | Human | Esophagus | ESCC | 5.33e-16 | 1.49e-01 | 0.1327 |
| 729991 | BORCS8 | P8T-E | Human | Esophagus | ESCC | 3.79e-06 | 1.51e-01 | 0.0889 |
| 729991 | BORCS8 | P9T-E | Human | Esophagus | ESCC | 3.07e-03 | 1.50e-01 | 0.1131 |
| 729991 | BORCS8 | P10T-E | Human | Esophagus | ESCC | 1.68e-09 | 1.75e-01 | 0.116 |
| 729991 | BORCS8 | P11T-E | Human | Esophagus | ESCC | 2.61e-06 | 2.05e-01 | 0.1426 |
| 729991 | BORCS8 | P12T-E | Human | Esophagus | ESCC | 1.48e-05 | 1.19e-01 | 0.1122 |
| 729991 | BORCS8 | P15T-E | Human | Esophagus | ESCC | 7.98e-12 | 1.87e-01 | 0.1149 |
| 729991 | BORCS8 | P16T-E | Human | Esophagus | ESCC | 5.06e-08 | 9.01e-02 | 0.1153 |
| 729991 | BORCS8 | P19T-E | Human | Esophagus | ESCC | 8.52e-04 | 3.43e-01 | 0.1662 |
| 729991 | BORCS8 | P20T-E | Human | Esophagus | ESCC | 9.62e-14 | 1.76e-01 | 0.1124 |
| Page: 1 2 3 4 5 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Esophagus |  | ESCC: Esophageal squamous cell carcinoma |
| HGIN: High-grade intraepithelial neoplasias | ||
| LGIN: Low-grade intraepithelial neoplasias | ||
| Liver |  | HCC: Hepatocellular carcinoma |
| NAFLD: Non-alcoholic fatty liver disease | ||
| Oral Cavity |  | EOLP: Erosive Oral lichen planus |
| LP: leukoplakia | ||
| NEOLP: Non-erosive oral lichen planus | ||
| OSCC: Oral squamous cell carcinoma |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD |  |
| Colorectum | SER |  |
| Colorectum | MSS |  |
| Colorectum | MSI-H |  |
| Colorectum | FAP |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| Page: 1 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| Page: 1 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| BORCS8 | SNV | Missense_Mutation | novel | c.35N>G | p.Lys12Arg | p.K12R | Q96FH0 | protein_coding | tolerated(0.35) | benign(0.017) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
| BORCS8 | SNV | Missense_Mutation | rs566625799 | c.259N>A | p.Val87Met | p.V87M | Q96FH0 | protein_coding | deleterious(0) | possibly_damaging(0.542) | TCGA-QG-A5Z2-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
| BORCS8 | SNV | Missense_Mutation | novel | c.22N>A | p.Leu8Ile | p.L8I | Q96FH0 | protein_coding | tolerated(0.39) | benign(0.031) | TCGA-AX-A2HC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | PD |
| Page: 1 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |